![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/10\/4000-1-23.jpg\")
<\/p>\n<\/p>\n
Former Attorney General of Louisiana<\/span>, Charles C. Foti, Jr., Esq.<\/span>, a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Vaxart, Inc. <\/p>\n In early 2020, the Company, which focuses on vaccination research and development, began working on a vaccine for COVID-19. Through mid-2020, the Company consistently touted its progress, including entering into a large scale manufacturing agreement and its selection for the U.S. Government’s flagship initiative to quickly develop a COVID-19 vaccine, Operation Warp Speed (“OWS”), which included significant government funding. Then, in July 2020<\/span>, media reports revealed that the Company had not been selected for OWS, it had merely entered its vaccine into a non-human primate trial organized by OWS.<\/p>\n Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws.<\/p>\n KSF’s investigation is focusing on whether Vaxart’s officers and\/or directors breached their fiduciary duties to Vaxart’s shareholders or otherwise violated state or federal laws. <\/p>\n If you have information that would assist KSF in its investigation, or have been a long-term holder of Vaxart shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-vxrt\/ to learn more.<\/p>\n About Kahn Swick & Foti, LLC<\/p>\n KSF, whose partners include former Louisiana<\/span> Attorney General Charles C. Foti, Jr.<\/span>, is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York<\/span>, California<\/span> and Louisiana<\/span>.<\/p>\n To learn more about KSF, you may visit www.ksfcounsel.com.<\/p>\n Contact:<\/p>\n Kahn Swick & Foti, LLC Tags:<\/b> Kahn Swick & Foti, LLC
Lewis Kahn<\/span>, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA<\/span> 70163<\/p>\nSee Campaign: <\/strong>http:\/\/www.ksfcounsel.com<\/a>
Contact Information:<\/b>
Kahn Swick & Foti, LLC
\nLewis Kahn, Managing Partner
\nlewis.kahn@ksfcounsel.com
\n1-877-515-1850
\n1100 Poydras St., Suite 3200
\nNew Orleans, LA70163<\/p>\n
<\/a>, Wire<\/a>, Legal Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
\nLewis Kahn, Managing Partner
\nlewis.kahn@ksfcounsel.com
\n1-877-515-1850
\n1100 Poydras St., Suite 3200
\nNew Orleans, LA\u00a070163<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Vaxart, Inc. In early 2020, the Company, which focuses on vaccination research and development, began working on a vaccine for COVID-19. Through mid-2020, the Company consistently … Continue reading VAXART INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. – VXRT<\/span><\/a> Continue Reading